A generic Triglide drug will not become available until at least 2021, which is when the patent for Triglide expires. Until then, you should not buy any drug sold as a generic form of Triglide -- these drugs could be fake, substandard, and potentially dangerous. Also, it is important not to confuse a drug's active ingredient with its "generic name." Fenofibrate is Triglide's active ingredient, not a generic version of the drug.
Triglide™ (fenofibrate) is a prescription medication that has been licensed to treat several conditions. These Triglide uses include:
- Lowering cholesterol levels in patients with hypercholesterolemia (high cholesterol). Triglide can reduce both total and LDL cholesterol (bad cholesterol) and raise HDL cholesterol (good cholesterol).
- Lowering triglyceride levels in patients with hypertriglyceridemia (high triglycerides). Triglycerides are fat-like substances found in the body.
Triglide is manufactured by SkyePharma Production for Sciele Pharma, Inc., and is currently protected by a patent that prevents any generic Triglide from being manufactured.
However, if you search the Internet for a generic Triglide, you will find a number of companies claiming to sell it. The fact is that these medicines are probably fake, substandard, and potentially dangerous. You should not buy any generic Triglide until there is an approved generic available.
The patent for Triglide currently expires in 2021. This is the earliest predictable date that a generic version of Triglide could become available. However, there are other circumstances that could come up to extend or shorten the exclusivity period of Triglide. This could include such things as lawsuits or other patents for specific Triglide uses. Once Triglide goes off patent, there may be several companies that manufacture a generic Triglide drug.